Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stem cell technology promises better grafts:

This article was originally published in Clinica

Executive Summary

The US company Progenitor has received a patent for its technology for processing blood stem cells capable of developing into blood or blood vessel cells. These could be used in bone marrow transplantation, vascular grafts, coatings and other therapeutic applications. The Menlo Park, California-based firm grows stem cells from the yolk sac, a tissue that appears very briefly in the early development of mammals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081317

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel